City

Houston (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

Ziopharm Oncology (1)

Intervention

autologous cd19-cd8-cd28-cd3zeta-car-mbil15-her1t t cells (1)

cyclophosphamide (1)

fludarabine (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

b acute lymphoblastic leukemia with t(v;11q23.3); kmt2a rearranged

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic

Terminated

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
+16 more

Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
+2 more

Houston, Texas

M D Anderson Cancer Center

May 28, 2021